Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Singnurkar

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Clinical Nuclear Medicine|October 21, 2006
The "pirate sign" in fibrous dysplasiaAmit Singnurkar, Chris Rush
Annals of Nuclear Medicine|March 30, 2017
Comparison of 18F-FDG-PET/CT and 18F-FDG-PET/MR imaging in oncology: a systematic reviewAmit Singnurkar, Raymond Poon, Ur Metser
Journal of Neuro-Oncology|December 11, 2022
18F-FET-PET imaging in high-grade gliomas and brain metastases: a systematic review and meta-analysisAmit Singnurkar, Raymond Poon, Jay Detsky
AJR. American Journal of Roentgenology|July 17, 2024
Head-to-Head Comparison of the Diagnostic Performance of FDG PET/CT and FDG PET/MRI in Patients With Cancer: A Systematic Review and Meta-AnalysisAmit Singnurkar, Raymond Poon, Ur Metser
Clinical Nuclear Medicine|June 27, 2008
Intensity of FDG uptake is not everything: synchronous liposarcoma and fibrous dysplasia in the same patient on FDG PET-CT imagingMathieu Charest, Amit Singnurkar, Marc Hickeson, et al.
Skeletal Radiology|June 26, 2007
The appearance of Mazabraud's syndrome on 18F-FDG PET/CTAmit Singnurkar, J P Phancao, Deep S Chatha, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2010
18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesionsAmit Singnurkar, Stephen B Solomon, Mithat Gönen, et al.
Clinical Nuclear Medicine|October 9, 2015
18F-FDG-PET/CT in the Staging and Management of Melanoma: A Prospective Multicenter Ontario PET Registry StudyAmit Singnurkar, Jonathan Wang, Anthony M Joshua, et al.
Clinical Nuclear Medicine|September 13, 2023
68 Ga-DOTATATE PET/CT in the Initial Diagnosis of Patients With Clinical, Imaging, and/or Biochemical Suspicion of a Neuroendocrine TumorUr Metser, Shereen Ezzat, Simron Singh, et al.
Cancer Treatment and Research Communications|November 28, 2020
The impact of synchronous malignancies on survival in patients with early stage curable non-small-cell lung cancerAmit Singnurkar, Anand Swaminath, Ur Metser, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Clinical Nuclear Medicine|October 21, 2006
The "pirate sign" in fibrous dysplasiaAmit Singnurkar, Chris Rush
Annals of Nuclear Medicine|March 30, 2017
Comparison of 18F-FDG-PET/CT and 18F-FDG-PET/MR imaging in oncology: a systematic reviewAmit Singnurkar, Raymond Poon, Ur Metser
Journal of Neuro-Oncology|December 11, 2022
18F-FET-PET imaging in high-grade gliomas and brain metastases: a systematic review and meta-analysisAmit Singnurkar, Raymond Poon, Jay Detsky
AJR. American Journal of Roentgenology|July 17, 2024
Head-to-Head Comparison of the Diagnostic Performance of FDG PET/CT and FDG PET/MRI in Patients With Cancer: A Systematic Review and Meta-AnalysisAmit Singnurkar, Raymond Poon, Ur Metser
Clinical Nuclear Medicine|June 27, 2008
Intensity of FDG uptake is not everything: synchronous liposarcoma and fibrous dysplasia in the same patient on FDG PET-CT imagingMathieu Charest, Amit Singnurkar, Marc Hickeson, et al.
Skeletal Radiology|June 26, 2007
The appearance of Mazabraud's syndrome on 18F-FDG PET/CTAmit Singnurkar, J P Phancao, Deep S Chatha, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2010
18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesionsAmit Singnurkar, Stephen B Solomon, Mithat Gönen, et al.
Clinical Nuclear Medicine|October 9, 2015
18F-FDG-PET/CT in the Staging and Management of Melanoma: A Prospective Multicenter Ontario PET Registry StudyAmit Singnurkar, Jonathan Wang, Anthony M Joshua, et al.
Clinical Nuclear Medicine|September 13, 2023
68 Ga-DOTATATE PET/CT in the Initial Diagnosis of Patients With Clinical, Imaging, and/or Biochemical Suspicion of a Neuroendocrine TumorUr Metser, Shereen Ezzat, Simron Singh, et al.
Cancer Treatment and Research Communications|November 28, 2020
The impact of synchronous malignancies on survival in patients with early stage curable non-small-cell lung cancerAmit Singnurkar, Anand Swaminath, Ur Metser, et al.
Pageof 3